|

PCNA Inhibitor AOH1996 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Also known as: AOH, AOH 1996, AOH-1996, AOH1996, Proliferating Cell Nuclear Antigen Inhibitor AOH1996

Pipeline

Phase 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Leiomyosarcomas1
  • Synovial Sarcomas1
  • Osteosarcoma1
  • Pancreatic Cancer1
  • Refractory Malignant Solid Neoplasm1

Scottsdale, Arizona1 trial

AOH1996 for the Treatment of Refractory Solid Tumors

Honor Health Research and Innovation Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.